PpJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi‑dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first‑in‑class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science‑based start‑up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. /ppAs Finance Business Partner, you will serve as a true strategic finance partner to our Chemistry, Manufacturing Controls (CMC), and Asset development teams where you will translate complex drug development activity into financial clarity and help make better, faster decisions. /ph3What You Will Do /h3ulliAct as the primary finance business partner for TechOps/CMC and Asset development teams – building trusted relationships and providing decision‑relevant financial perspective. /liliTranslate RD strategy and pipeline milestones into financial plans, forecasts, and scenario analyses that guide investment decisions. /liliProactively flag risks and opportunities, offering financially sound recommendations rather than simply reporting variances. /liliOwn the end‑to‑end budgeting, forecasting, and long‑range planning processes for assigned RD functions. /liliBuild and maintain robust financial models that reflect the realities of drug development – including clinical milestones, manufacturing scale‑up, regulatory timelines, and external spend. /liliPartner with PMO, Procurement and Alliance Management to ensure accurate accruals and PO management for CRO, CMO, and other RD vendor contracts. /liliMonitor actuals vs. plan, provide meaningful variance commentary, and continuously improve forecast accuracy. /liliDevelop dashboards, KPI scorecards, and financial narratives that give RD leadership a clear, real‑time view of financial performance. /liliApply analytical rigour to answer business questions – from program‑level cost‑per‑patient analyses to portfolio prioritisation trade‑offs. /liliLeverage argenx's Oracle EPM/PPM ecosystem and emerging AI/data tools to drive efficiency and elevate analytical depth. /liliRepresent Finance in CMC programme reviews, Asset meetings, and project governance forums. /liliCollaborate closely with the broader FPA team (RD, Corporate) and the RD FPA Lead to ensure consolidated financial coherence. /liliSupport with ad hoc analyses and special projects. /liliDrive automation and AI adoption in day‑to‑day operations. /li /ulh3What You Bring /h3pbExperience Knowledge /b /pulli8+ years of progressive FPA or finance business partnering experience, with meaningful time in pharma, biotech, or life sciences. /liliDeep working knowledge of the drug development process – from IND‑enabling studies through Phase I–III, CMC scale‑up, regulatory submissions, and launch readiness. /liliProven track record as a finance partner who influences decisions, not just supports reporting. /liliExperience managing complex RD budgets including CRO/CDMO contracts, milestone‑based payments, and accrual methodologies. /liliProficiency with EPM/ERP tools (Oracle EPM/PPM a strong plus) and advanced Excel financial modelling. /liliMaster's degree in Finance, Economics, Accounting, or equivalent; CPA/CIMA/CFA qualification is a plus. /li /ulpbMindset Ways of Working /b /pulliCuriosity‑driven – you ask why, not just what. You want to understand the science, strategy, and operational context behind the numbers. /liliAnalytical rigour paired with the ability to communicate complexity simply to senior non‑finance stakeholders. /liliComfortable operating in ambiguity and fast‑paced environments; self‑directed and proactive. /liliCollaborative by nature – you actively build relationships across functions and bring others along. /liliHigh standards for output quality and attention to detail, without losing sight of the bigger picture. /li /ulh3Equal Opportunity /h3pAll applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, colour, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. /p /p #J-18808-Ljbffr